Rapid ultraperformance liquid chromatography-tandem mass spectrometry method for quantification of oxcarbazepine and its metabolite in human plasma

Biomedical Chromatography

Volumn 25, Issue 7, 2011, Pages 751-759

  Bhatt, Mitesh ^a,b   Shah, Sanjay ^a   Shivprakash, ^b  

^a V L Shah Commerce College Pilvai   (India)

^b Synchron Research Services Private Limited   (India)

Author keywords

10,11 dihydro 10 hydroxycarbamazepine; Acquity; Human plasma; Imipramine; LC MS MS; Oxcarbazepine; UPLC

Indexed keywords

AMIDES; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; PLASMA (HUMAN); QUALITY CONTROL;

10,11-DIHYDRO-10-HYDROXYCARBAMAZEPINE; ACQUITY; HUMAN PLASMAS; IMIPRAMINE; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS; OXCARBAZEPINE; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRIES; UPLC;

METABOLITES;

IMIPRAMINE; LICARBAZEPINE; OXCARBAZEPINE;

ACCURACY; ARTICLE; BIOEQUIVALENCE; DRUG DETERMINATION; ELECTROSPRAY; FLOW RATE; HUMAN; MALE; NORMAL HUMAN; PLASMA; QUALITY CONTROL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 79958228221     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1510     Document Type: Article

References (23)

1. Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP and Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. Journal of Chromatography B 2005; 825: 80-90.
2. Bugamelli F, Sabbioni C, Mandrioli R, Kenndler E, Albani F and Raggi MA. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction. Analytica Chimica Acta 2002; 472: 1-10.
3. Contin M, Balboni M, Callegati E, Candela C, Albani F, Riva R and Baruzzi A. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. Journal of Chromatography B 2005; 828: 113-117.
4. Dams R, Huestis MA, Lambert WE and Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. Journal of the American Society for Mass Spectrometry 2003; 14: 1290-1294.
5. de Sousa Maia MD, do Nascimento DF, Martins IL, Cunha AN, Goncalves de Lima FE, Frota Bezerra FA, de Moraes MO and Amaral de Moraes ME. Simultaneous quantitative analysis of oxcarbazepine and 10, 11-dihydro-10-hydroxycarbamazepine in human plasma by liquid chromatography-electrospray tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2007; 45: 304-311.
6. De Villiers A, Lestremau F, Szucs R, Gélébart S, David F and Sandra P. Evaluation of ultraperformance liquid chromatography Part I. Possibilities and limitations. Journal of Chromatography A 2006; 1127: 60-69.
7. FDA. Guidance for Industry. Bioanalytical Method Validation. US Department of Health and Human Services, FDA, CDER, CVM: Washington, DS, 2001; available at:
8. FDA. Guidance for Industry: Bioavailability Studies for Orally Administered Drug - Products - General Considerations. US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research: Washington, DC, 2000.
9. Flesch G. Overview of the clinical pharmacokinetics of oxcarbazepine. Clinical Drug Investigation 2004; 24: 185-203.
10. González-Esquivel DF, Ortega-Gavilán M, Alcántara-López G and Jung-Cook H. Plasma level monitoring of oxcarbazepine in epileptic patients. Archives of Medical Research 2000; 31: 202-205.
11. Klys M, Rojek S and Bolechała F. Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). Journal of Chromatography B 2005; 825: 38-46.
12. Lanckmans K, Clinckers R, Van Eeckhaut A, Sarre S, Smolders I and Michotte Y. Use of microbore LC-MS/MS for the quantification of oxcarbazepine and its active metabolites in rat brain microdialysis samples. Journal of Chromatography B 2006; 831: 205-212.
13. Mandrioli R, Ghedini N, Albani F, Kenndler E and Raggi MA. Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction. Journal of Chromatography B 2003; 783: 253-263.
14. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Strategies for the assessment of matrix effect inquantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019-3030.
15. Paglia G, D'Apolito O, Garofalo D, Scarano C and Corso G. Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum. Journal of Chromatography B, Analytical Technologies in the Biomedical and life Science 2007; 860: 153-159.
16. Perucca E. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundamental and Clinical Pharmacology 2001; 15: 405-417.
17. Rouan MC, Decherf M, Le Clanche V, Lecaillon JB and Godbillon J. Automated microanalysis of oxcarbazepine and its monohydroxy and transdiol metabolites in plasma by liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 1994; 658: 167-172.
18. 14C-oxcarbazepine in man. Xenobiotica 1986; 16: 769-778.
19. Silva LC, Oliveira LS, Mendes GD, Garcia G, Pereira AS and De Nucci G. Quantification of isosorbide 5-mononitrate in human plasma by liquid chromatography-tandem mass spectrometry using atmospheric pressure photoionization. Journal of Chromatography B 2006; 832: 302-306.
20. Srinubabu G, Ratnam BV, Rao AA and Rao MN. Development and validation of LC-MS/MS method for the quantification of oxcarbazepine in human plasma using an experimental design. Chemical and Pharmaceutical Bulletin 2008; 56: 28-33.
21. Volosov A, Xiaodong S, Perucca E, Yagen B, Sintov A and Bialer M. Enantioselective pharmacokinetics of 10- hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clinical Pharmacology and Therapeutics 1999; 66: 547-553.
22. Von unruh GE and Paar WD. Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma. Journal of Chromatography 1985; 345: 67-76.
23. Von unruh GE and Paar WD. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10, 11-trans-diol. Biological Mass Spectrometry 1986; 13: 651-656.